EKSO
EKSO BIONICS HOLDINGS, INC.
Insiders bought $1.2M net in the last 90 days ·1 seller, 3 buyers· latest Form 4 filed Mar 20, 2026
Insider Buying
$1.2M
reported purchases (SEC code P)
Insider Selling
$232K
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Mar 20, 2026
Jones Jason C
EKSO BIONICS HOLDINGS, INC. (EKSO) has 14 SEC Form 4 filings (21 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Mar 20, 2026.
Inside the rolling window, 4 insiders at EKSO BIONICS HOLDINGS, INC. reported 9 open-market purchases totaling $1.2M and 6 open-market sales totaling $232K. The most active filer is 10% Owner ASHER DANIEL with 7 filings. Insiders have net bought $972K over the trailing 6 months. The most recent open-market filing is a purchase of 1,308 shares by Chief Operating Officer Jones Jason C, dated Mar 16, 2026, worth $15K.
- Industry:Medical - Equipment & Services
- CEO:Scott G. Davis
- Employees:53
- HQ:San Rafael, CA, US
- IPO:2014-01-15
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Operating Officer | Purchase | 1,308 | $15K | Mar 20 | — | SEC ↗ | |
Wong JeromeFirst in 3 months | Chief Financial Officer | Purchase | 1,308 | $15K | Mar 20 | — | SEC ↗ |
| 10% Owner | Purchase | 16,740 | $203K | Feb 20 | — | SEC ↗ | |
| 10% Owner | Purchase | 194 | $2K | Feb 17 | — | SEC ↗ | |
| 10% Owner | Purchase | 4,800 | $48K | Feb 17 | — | SEC ↗ | |
| 10% Owner | Purchase | 10,200 | $101K | Feb 17 | — | SEC ↗ | |
| 10% Owner | Purchase | 20,611 | $200K | Feb 17 | — | SEC ↗ | |
| 10% Owner | Purchase | 39,032 | $374K | Feb 17 | — | SEC ↗ | |
| 10% Owner | Purchase | 27,192 | $246K | Feb 17 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 1,320 | $12K | Jan 7 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 1,238 | $6K | Dec 10 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 270 | $1K | Dec 10 | — | SEC ↗ | |
Davis Scott G.First filing | CEO | Sale | 23,315 | $112K | Nov 12 | — | SEC ↗ |
Wong JeromeFirst filing | Chief Financial Officer | Sale | 11,288 | $54K | Nov 12 | — | SEC ↗ |
Jones Jason CFirst filing | Chief Operating Officer | Sale | 9,723 | $47K | Nov 12 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does EKSO have?
EKSO BIONICS HOLDINGS, INC. (EKSO) has 14 SEC Form 4 filings (21 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Mar 20, 2026.
When was the most recent SEC Form 4 filing for EKSO?
The most recent Form 4 filing for EKSO on Tracefour is dated Mar 20, 2026.
Who is the most active insider at EKSO?
The most active SEC Form 4 filer at EKSO in the rolling window is 10% Owner ASHER DANIEL, with 7 filings.
What is the net insider flow at EKSO over the last 6 months?
Over the trailing 180 days, insiders at EKSO have net bought $972K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at EKSO in the current window?
Inside the rolling window, insiders at EKSO bought $1.2M and sold $232K based on SEC Form 4 filings.
Can I get alerts for EKSO insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at EKSO BIONICS HOLDINGS, INC. (EKSO). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.